Civica, Inc. (Civica Rx) was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q3 2022, we have provided nearly 100 million vials of essential medicines to hospitals, enough to help treat close to 40 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin beginning in 2024. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem, including payers, to bring low-cost insulin to people living with diabetes at no more than $30 a vial and no more than $55 for a pack of five pre-filled pens, regardless of insurance status. WHY CIVICA? Because patients should have the essential medicines they need when they need them. As a rapidly growing, entrepreneurial, nonprofit generic drug company our mission is to ensure quality generic medicines are accessible and affordable to everyone.